Guardion Health Sciences Announces Declaration of Cash Distribution
Guardion Health Sciences has announced a cash distribution of $3.25 per share of common stock to stockholders of record as of October 30, 2024. The distribution is expected to be paid by December 27, 2024. This follows the company's previously announced legal dissolution, with stockholders approving the Plan of Liquidation and Dissolution at a special meeting on May 31, 2024.
The company closed its stock transfer books on October 30, 2024, after which stockholders retain only the right to receive distributions. Guardion will continue operations for three years solely to wind down business affairs, settle suits, dispose of property, discharge liabilities, and distribute remaining assets to stockholders in accordance with Delaware law.
Guardion Health Sciences ha annunciato una distribuzione di cassa di 3,25 dollari per azione delle azioni ordinarie agli azionisti registrati al 30 ottobre 2024. Si prevede che la distribuzione venga effettuata entro il 27 dicembre 2024. Ciò segue la precedente annuncio della dissoluzione legale dell'azienda, con gli azionisti che hanno approvato il Piano di Liquidazione e Dissoluzione in una riunione speciale del 31 maggio 2024.
L'azienda ha chiuso i registri di trasferimento azionari il 30 ottobre 2024, dopo il quale gli azionisti mantengono solo il diritto di ricevere le distribuzioni. Guardion continuerà le operazioni per tre anni esclusivamente per chiudere gli affari, risolvere le cause, disporre di beni, estinguere le passività e distribuire gli attivi residui agli azionisti in conformità con la legge del Delaware.
Guardion Health Sciences ha anunciado una distribución en efectivo de 3,25 dólares por acción de acciones ordinarias a los accionistas registrados al 30 de octubre de 2024. Se espera que la distribución se pague antes del 27 de diciembre de 2024. Esto sigue el anuncio previo de la disolución legal de la empresa, con los accionistas que aprobaron el Plan de Liquidación y Disolución en una reunión especial el 31 de mayo de 2024.
La empresa cerró sus libros de transferencias de acciones el 30 de octubre de 2024, después de lo cual los accionistas mantienen solo el derecho a recibir distribuciones. Guardion continuará sus operaciones durante tres años únicamente para liquidar sus asuntos comerciales, resolver demandas, disponer de propiedades, saldar deudas y distribuir los activos restantes a los accionistas de acuerdo con la ley de Delaware.
Guardion Health Sciences는 2024년 10월 30일 기준 주주들에게 주당 3.25달러의 현금 배당금을 발표했습니다. 이 배당금은 2024년 12월 27일까지 지급될 예정입니다. 이는 회사가 이전에 발표한 법적 해산에 따른 것으로, 주주들은 2024년 5월 31일 특별 회의에서 청산 및 해산 계획을 승인했습니다.
회사는 2024년 10월 30일 주식 양도 장부를 폐쇄했으며, 그 이후로 주주들은 배당금 수령권만 유지합니다. Guardion은 사업 수정, 소송 해결, 자산 처분, 부채 청산 및 델라웨어 법에 따라 주주에게 잔여 자산을 분배하기 위해 향후 3년 동안만 운영을 지속할 것입니다.
Guardion Health Sciences a annoncé une distribution en espèces de 3,25 dollars par action d'actions ordinaires aux actionnaires inscrits au 30 octobre 2024. La distribution devrait être effectuée d'ici le 27 décembre 2024. Cela fait suite à l'annonce de dissolution légale de l'entreprise, les actionnaires ayant approuvé le Plan de Liquidation et de Dissolution lors d'une réunion spéciale le 31 mai 2024.
L'entreprise a fermé ses livres de transfert d'actions le 30 octobre 2024, après quoi les actionnaires ne conservent que le droit de recevoir des distributions. Guardion continuera ses opérations pendant trois ans uniquement pour liquider les affaires, régler les poursuites, disposer des biens, régler les dettes et distribuer les actifs restants aux actionnaires conformément à la loi du Delaware.
Guardion Health Sciences hat eine Barausschüttung von 3,25 US-Dollar pro Aktie an die am 30. Oktober 2024 eingetragenen Aktionäre angekündigt. Die Ausschüttung soll bis zum 27. Dezember 2024 erfolgen. Dies folgt auf die zuvor angekündigte rechtliche Auflösung des Unternehmens, wobei die Aktionäre den Plan zur Liquidation und Auflösung in einer Sondersitzung am 31. Mai 2024 genehmigten.
Das Unternehmen hat am 30. Oktober 2024 die Aktienübertragungsbücher geschlossen, wonach die Aktionäre nur das Recht auf Ausschüttungen behalten. Guardion wird seine Geschäftstätigkeit drei Jahre lang ausschließlich fortsetzen, um geschäftliche Angelegenheiten abzuwickeln, Klagen zu klären, Vermögenswerte zu veräußern, Verbindlichkeiten zu begleichen und verbleibende Vermögenswerte gemäß dem Recht von Delaware an die Aktionäre zu verteilen.
- Cash distribution of $3.25 per share to stockholders
- Clear timeline for distribution payment by December 27, 2024
- Company is in process of complete dissolution
- No further business activities except for wind-down operations
- Stock transfer books permanently closed as of October 30, 2024
HOUSTON, TEXAS, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) today announced that its Board of Directors declared a cash distribution (the “Distribution”) in an amount equal to
As previously announced, Guardion closed its stock transfer books as of October 30, 2024 (the “Effective Date”), and record holders of shares of the Company’s Common Stock ceased to have any rights in respect of such shares of Common Stock, except the right to receive distributions, if any, pursuant to and in accordance with the Company’s Plan of Liquidation and Dissolution approved by stockholders at the Company’s special meeting of stockholders held on May 31, 2024 and under the General Corporation Law of the State of Delaware (the “DGCL”).
After the Effective Date, Guardion has not engaged, and will not engage in any business activities except to the extent necessary to preserve the value of any remaining assets, complete the wind down of its business affairs and distribute its assets in accordance with the Plan. Under the DGCL, Guardion will be continued for the term of three years following the Effective Date, or for such longer period as the Delaware Court of Chancery directs, for the purposes of prosecuting and defending suits by or against it and of enabling it to gradually settle and close the business, to dispose of and convey its property, to discharge its liabilities and to distribute to stockholders any remaining assets.
Forward-Looking Statements
The matters described herein may contain “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements contain information about the Company’s expectations, beliefs, plans or intentions regarding its business plans, financial condition, and other similar matters. Statements preceded by, followed by or that otherwise include the words “believes,” “expects,” “anticipates,” “intends,” “projects,” “estimates,” “plans,” “hopes” and similar expressions or future or conditional verbs such as “will,” “should,” “would,” “may” and “could” are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing.
These statements are based on management’s current expectations and assumptions about future events, which are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict, and involve unknown risks and uncertainties that may individually or materially impact the matters discussed herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the amount and timing of cash distributions that may be made to stockholders.
Readers are cautioned not to place undue reliance on these forward-looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company’s filings with the SEC, which are available at the SEC’s website (www.sec.gov). The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
For more information about Guardion Health Sciences, Inc., Contact:
investors@guardionhealth.com
Phone: 1-800 873-5141 Ext 208
FAQ
How much is Guardion Health Sciences (GHSI) distributing per share to stockholders?
When will GHSI stockholders receive the cash distribution?
What happens to GHSI shares after October 30, 2024?
How long will Guardion Health Sciences (GHSI) continue operations after dissolution?
When did GHSI shareholders approve the Plan of Liquidation and Dissolution?
